ask our doctors

Fabry Disease

Get the facts on Fabry Disease treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Fabry Disease prevention, screening, research, statistics and other Fabry Disease related topics. We answer all your qestions about Fabry Disease.

Question: fabry disease?

Answer: http://healthlink.mcw.edu/article/921727118.html


Fabry Disease News

Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare ...

MarketWatch (press release)
The report provides an in-depth analysis of Fabry, Pompe, Mucopolysaccharidosis VI, Idiopathic Thrombocytopenic Purpura, Huntington's Disease and Ovarian cancer. The report examines the global orphan diseases therapeutics treatment usage patterns.
 

Amicus Therapeutics Announces First Quarter 2012 Financial Results

MarketWatch (press release)
Final enrollment on track by YE12 -- Current enrollment in Phase 2 Study 013 for Fabry disease includes patients in higher dose group of migalastat HCl (450 mg) co-administered with Fabrazyme and in lower dose group of migalastat HCl (150 mg) ...
 

Orphan Disease Therapeutics Market to 2018

SBWire (press release)
The report provides an in-depth analysis of Fabry, Pompe, Mucopolysaccharidosis VI, Idiopathic Thrombocytopenic Purpura, Huntington's Disease and Ovarian cancer. The report examines the global orphan diseases therapeutics treatment usage patterns.
 

Amicus Therapeutics Announces First Quarter 2012 Financial Results

GlobeNewsWire (press release)
Cash, cash equivalents and marketable securities totaled $108.2 million at March 31, 2012 -- A majority of patients enrolled in second global registration study (Study 012) of migalastat HCl monotherapy for Fabry disease. Final enrollment on track by ...
 

Big pharma and biotech increasingly tackling rare and niche diseases, new ...

The Pharma Letter
These include Duchenne muscular dystrophy (DMD), Gaucher disease, Philadelphia chromosome negative (Ph-) acute lymphocytic leukemia (ALL), Fabry disease, and idiopathic pulmonary fibrosis (IPF). One product, Pfizer's Elelyso (taliglucerase alfa) has ...
 

Orphan drugs to see growth through 2018, report finds

Drug Store News
Currently, there are more than 6000 orphan diseases recognized in the United States, defined as diseases affecting 200000 or fewer Americans and including such conditions as Gaucher disease and Fabry disease. European health authorities recognize ...
 

Protalix BioTherapeutics to Present at Three Upcoming Healthcare Conferences

MarketWatch (press release)
Protalix's development pipeline also includes the following product candidates: PRX-102, a modified version of the recombinant human alpha-GAL-A protein for the treatment of Fabry disease; PRX-105, a pegylated recombinant human acetylcholinesterase in ...
 

Shire 1Q profit grows as ADHD drug sales rise

BusinessWeek
Shire said revenue from its Fabry disease treatment Replagal sales improved 28 percent to $134.4 million. Fabry disease is a rare inherited disorder caused by the lack of an enzyme needed to break down a certain type of fat.
 

Sanofi First-Quarter Net Climbs 13% on Genzyme, Lantus

BusinessWeek
Patients in the US have returned to full dosing of the medicine, which treats a rare illness known as Fabry disease, Sanofi said today. In Europe, the process of moving the most severely affected patients to full dose of the drug also has begun, ...
 

RTT News

Sanofi Profit Rises On Genzyme Buy, Lantus Strength
RTT News